Intas Pharmaceuticals Limited Gemcitabine Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Gemcitabine Export Records India — #5 Exporter, 231 Shipments, $3.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Gemcitabine

India Pharmaceutical Trade Intelligence

$46.5M248 Suppliers125 CountriesHS 30049049

ExportsIndia → UNITED STATES16.8%India → BELGIUM12.7%

ImportsUNITED STATES → India$133.8M FRANCE → India$35.5M

#1 Supplier: FRESENIUS KABI #1 Buyer: YUSEN LOGISTICS

Intas Pharmaceuticals Limited — Gemcitabine Exporter #5 | $3.8M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Gemcitabine Exporter Profile

Indian Pharmaceutical Exporter · #5 for Gemcitabine · $3.8M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #5 Indian exporter of Gemcitabine with $3.8M in export value and 231 verified shipments. Intas Pharmaceuticals Limited holds a 7.9% market share in Gemcitabine exports across 17 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Gemcitabine Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Gemcitabine export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Gemcitabine?

Country	Value	Shipments	Share
UNITED STATES	$779.5K	17	34.5%
SOUTH AFRICA	$590.3K	26	26.1%
NETHERLANDS	$177.1K	26	7.8%
POLAND	$156.9K	16	6.9%
FRANCE

Who Are the Top Buyers of Gemcitabine from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$379.5K	9
AMERISOURCE HEALTH SERVICES	UNITED STATES	$300.0K	6
ACCORD HEALTHCARE C/O QESTMED	SOUTH AFRICA	$297.1K	11
XXCORXXHEAXXHCAXX B XX	NETHERLANDS	$150.0K	3
TO THE ORDER .	SOUTH AFRICA	$109.1K	6
EVERSANA LIFE SCIENCES SERVICES LLC	UNITED STATES	$100.0K	2
TO THE ORDER	MALTA	$94.8K	14
ACCORD HEALTHCARE C/O QESTMED (PTY)	SOUTH AFRICA	$94.3K	2
XXCORXXHEAXXHCAXX POXXKA XX ZXX O	POLAND	$91.2K	2
XXCORXXNL XX XXB	NETHERLANDS	$79.3K	2

Intas Pharmaceuticals Limited supplies Gemcitabine to 50 buyers globally. The largest buyer is EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES), followed by AMERISOURCE HEALTH SERVICES (UNITED STATES) and ACCORD HEALTHCARE C/O QESTMED (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Gemcitabine Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI GEMCITABINE RTU 100M	$255.1K	8
PHARMA DRUGS & MEDI ACCORD -GEMCITABINE	$94.3K	2
PHAR.DRUGS AND MED: CYTIGEM 200 EACH VIAL CONTAINS: GEMCITABINE HYDROCHLORIDE EQ.TO 200MG GEMCITABINE FREE BASE	$83.5K	4
GEMCITABINE100MG/ML 20ML	$81.6K	3
PHARMA DRUG&MED:ACCORD -GEMCITABINE 1G E	$71.9K	3
GEMCITABINE 100MG/ML20ML RTUACCORD-FRAN	$51.0K	2
PHR DRUGS&MEDI GEMCITABINE RTU 100MG/ML,	$50.8K	3
PHARMA DRUG&MED: CYTIGEM 1000 EACH VIALCONTAINS: GEMCITABINE HYDROCHLORIDE EQ.TO 1G GEMCITABINE FREE BASE	$50.5K	4
PHR DRUGS&MEDI GEMCITABINE RTU 100MG/ML	$50.0K	1
GEMCITABINE 100MG/ML20ML	$50.0K	1

Intas Pharmaceuticals Limited exports 147 distinct Gemcitabine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI GEMCITABINE RTU 100M with 8 shipments worth $255.1K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Gemcitabine Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	EUGIA PHARMA SPECIALITIES LIMITED	$5.9M	188	2	$31.4K
3	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$5.8M	137	3	$42.3K
5	INTAS PHARMACEUTICALS LIMITED ★	$3.7M	231	17	$16.0K
6	ACCURE LABS PRIVATE LIMITED	$3.1M	107	2	$29.0K
9	VENUS REMEDIES LIMITED	$2.2M	189	23	$11.6K

Intas Pharmaceuticals Limited ranks #5 among 248 Indian Gemcitabine exporters. Average shipment value of $16.0K compared to the market average of $147.4K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.

Which Indian Ports Ship Gemcitabine Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	538	18.3%
SAHAR AIR CARGO ACC (INBOM4)	393	13.4%
SAHAR AIR	370	12.6%
DELHI AIR	358	12.2%
Delhi Air	131	4.5%
HYDERABAD ICD (INSNF6)	88	3.0%
Bombay Air	77	2.6%
NHAVA SHEVA SEA (INNSA1)	66	2.2%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Gemcitabine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Gemcitabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 234 individual customs records matching Intas Pharmaceuticals Limited exporting Gemcitabine, covering 147 formulations to 18 countries via 50 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 125+ countries, 676+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Gemcitabine

Gemcitabine

Intas Pharmaceuticals Limited — Gemcitabine Exporter Profile

Intas Pharmaceuticals Limited — Gemcitabine Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Gemcitabine?

Who Are the Top Buyers of Gemcitabine from Intas Pharmaceuticals Limited?

What Is India's Total Gemcitabine Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Gemcitabine Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Gemcitabine Exporters?

What Gemcitabine Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Gemcitabine to Key Markets

United States — FDA

South Africa — SAHPRA

How Does Intas Pharmaceuticals Limited Compare to Nearest Gemcitabine Exporters?

Which Indian Ports Ship Gemcitabine Exports?

What Other Oncology Products Does Intas Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Gemcitabine Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Gemcitabine Export Data from Intas Pharmaceuticals Limited

Gemcitabine Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source